Sign in
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
LogoFinSMEs The Website About Venture Capital News
LogoFinSMEs The Website About Venture Capital News
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Home Tags Novartis Venture Fund

Tag: Novartis Venture Fund

Espislogen
UK

Epsilogen Closes £12.5M Series B Extension Financing

FinSMEs -
September 9, 2024
0
CatalYm Raises $150M in Series D Funding
Germany

CatalYm Raises $150M in Series D Funding

FinSMEs -
July 16, 2024
0
Exsilio Therapeutics
USA

Exsilio Therapeutics Raises $82M in Series A Financing

FinSMEs -
June 25, 2024
0
capstan
USA

Capstan Therapeutics Raises $175M in Series B Financing

FinSMEs -
March 21, 2024
0
Enterprise_Therapeutics
UK

Enterprise Therapeutics Closes £26M Series B Follow-on Financing

FinSMEs -
January 30, 2024
0
healthcare
UK

AstronauTx Raises £48M in Series A Financing

FinSMEs -
October 9, 2023
0
Fore Biotherapeutics
USA

Fore Biotherapeutics Raises $75M in Series D Financing

FinSMEs -
August 25, 2023
0
Tagworks Pharmaceuticals BV
Netherlands

Tagworks Pharmaceuticals Raises $65M in Series A Financing

FinSMEs -
June 22, 2023
0
Mediar Therapeutics logo
USA

Mediar Therapeutics Raises $105M in Funding

FinSMEs -
March 15, 2023
0
cancer
Germany

CatalYm Closes EUR 50M Series C Financing

FinSMEs -
November 22, 2022
0
splicebio
Spain

SpliceBio Raises €50M in Series A Financing

FinSMEs -
February 21, 2022
0
Sumant Ramachandra
USA

ImmPACT Bio Closes $111M Series B Financing

FinSMEs -
January 21, 2022
0
healthcare
UK

LoQus23 Therapeutics Raises £7M in Seed Financing

FinSMEs -
November 25, 2021
0
healthcare
USA

Exo Therapeutics Raises $78M in Series B Financing

FinSMEs -
October 11, 2021
0
healthcare
USA

Expansion Therapeutics Raises $80M in Series B Financing

FinSMEs -
September 29, 2021
0
123...6Page 1 of 6
  • Contact
  • About
  • Privacy Policy
  • Advertise with Us
  • Disclaimer
  • GDPR
  • Terms & Conditions

Follow Us

Twitter